delete PART 717—SPECIAL CONTRACTING METHODS
Prohibits U.S. government procurement of foreign pharmaceutical products covered by unexpired U.S. patents unless authorized by patent holder, with policies in USAID ADS Chapter 312.
Protects pharmaceutical patent holders from foreign competition in government contracts, artificially inflating drug prices and limiting access to potentially cheaper alternatives. This regulatory barrier serves incumbent pharmaceutical companies at taxpayer expense while undermining free market principles and international trade.